GS
CVS icon

GTS Securities’s CVS Health CVS Stock Holding History

GTS Securities’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Sell
2,901
-1,094
-27% -$97.7K 0.01% 977
2026
Q1 		$287K Sell
3,995
-9,371
-70% -$722K 0.01% 1129
2025
Q4 		$1.06M Buy
13,366
+6,834
+105% +$539K 0.04% 423
2025
Q3 		$492K Buy
6,532
+1,751
+37% +$120K 0.02% 737
2025
Q2 		$330K Sell
4,781
-10,052
-68% -$659K 0.01% 863
2025
Q1 		$1M Sell
14,833
-2,870
-16% -$172K 0.04% 390
2024
Q4 		$795K Sell
17,703
-295,423
-94% -$16.6M 0.04% 432
2024
Q3 		$19.7M Buy
313,126
+49,235
+19% +$2.87M 0.04% 269
2024
Q2 		$15.6M Buy
263,891
+157,792
+149% +$9.87M 0.03% 324
2024
Q1 		$8.46M Sell
106,099
-104,268
-50% -$7.96M 0.02% 587
2023
Q4 		$16.6M Sell
210,367
-5,557
-3% -$396K 0.03% 395
2023
Q3 		$15.1M Buy
215,924
+95,409
+79% +$6.76M 0.03% 429
2023
Q2 		$8.33M Buy
+120,515
New +$8.58M 0.26% 72

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

GTS Securities's CVS Position: Q2 2026 in Review

GTS Securities reduced its CVS Health (CVS) stake by 27% in Q2 2026, selling an estimated $97.7K and leaving 2,901 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #977.

GTS Securities first reported a position in CVS in Q2 2023 and has held it in 13 quarters since. The position peaked at $19.7M in Q3 2024. 2,070 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • GTS Securities held 2,901 shares of CVS Health worth $300K as of Q2 2026.
  • GTS Securities sold 1,094 CVS Health shares in Q2 2026, an estimated $97.7K.
  • CVS Health made up 0.01% of GTS Securities's portfolio in Q2 2026, its #977 holding.
  • GTS Securities first reported a position in CVS Health in Q2 2023 and has held it in 13 quarters since.
  • GTS Securities's CVS Health position peaked at $19.7M in Q3 2024.
  • 2,070 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.